It is frequently associated with metabolic signalling, appetite-regulation pathways, glucose-response models, energy expenditure, and weight-management
Current guidelines from the European Society of Cardiology recommend SGLT2Is as a treatment option for HFpEF patients with diabetes or CKD
1, flavor, glycerin, microcrystalline cellulose and carboxymethylcellulose sodium, propylene glycol, purified water, simethicone emulsion, sodium benzoate, sucralose, titanium dioxide, xanthan gum
Diarrhea associated with weight loss injections likely results from multiple factors, though the precise mechanisms are not fully understood
Other general confounding factors noted in patients of these studies include but are not limited to obesity, alcohol, nicotine, or marijuana